[Results of treatments with IGF-I].

doi:10.1016/0929-693x(96)86021-0

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[Results of treatments with IGF-I].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie - 1 Jan 1996

Chatelain P, Carel J C, Nicolino M, Savage M O, Chaussain J L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Child, Preschool
Share to Dwarfism, Pituitary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Hormone

Share to Insulin-Like Growth Factor I

Share to Phenotype

Share to Syndrome

Source

Open in PubMed

Identifiers

PMID: 8795996
DOI: 10.1016/0929-693x(96)86021-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Results of treatments with IGF-I].PMID 8795996Read ↗

[Growth hormone deficiency].Semantic proximity Read ↗

PAPP-A and the IGF systemSemantic proximity Read ↗

[Growth factors in the testicle].Semantic proximity Read ↗

[The treatment of diabetes insipidus in 1999].Semantic proximity Read ↗

Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary reportSemantic proximity Read ↗

Growth hormone and IGF-1.Semantic proximity Read ↗

The decline and fall of the IGF‐I receptorSemantic proximity Read ↗

[Perspectives and future developments of epidermal growth factor receptors inhibitors].Semantic proximity Read ↗

Therapy for 6.5-7.5 Years with Recombinant Insulin-Like Growth Factor I in Children with Growth Hormone Insensitivity Syndrome: A Clinical Research Center StudySemantic proximity Read ↗

Hematopoietic growth factors: ESMO Recommendations for the applicationsSemantic proximity Read ↗

[GH receptor function and its evaluation].Semantic proximity Read ↗

[FGF23 (phosphatonin)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.